Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria

Molecular Genetics and Metabolism

Volumn 78, Issue 4, 2003, Pages 291-294

  Heeney, Matthew M ^a,b   Ormsbee, Susan M ^a   Moody, M Anthony ^a   Howard, Thad A ^a   DeCastro, Carlos M ^a   Ware, Russell E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

A1 protein, human; Apoptosis; Hemoglobinuria, paroxysmal nocturnal; MCL1 protein; RAD23 protein, human; RhoA GTP binding protein

Indexed keywords

PROTEIN MCL 1; RHO FACTOR;

APOPTOSIS; ARTICLE; BLOOD CELL; BONE MARROW; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATIENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 0037388499     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00047-7     Document Type: Article

References (29)

1. Hillmen P., Bessler M., Mason P.J., Watkins W.M., Luzzatto L. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. USA. 90:1993;5272-5276.
2. Takahashi M., Takeda J., Hirose S., Hyman R., Inoue N., Miyata T., Ueda E., Kitani T., Medof M.E., Kinoshita T. Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med. 177:1993;517-521.
3. Norris J., Hall S., Ware R.E., Kamitani T., Chang H.M., Yeh E., Rosse W.F. Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step. Blood. 83:1994;816-821.
4. Takeda J., Miyata T., Kawagoe K., Iida Y., Endo Y., Fujita T., Takahashi M., Kitani T., Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 73:1993;703-711.
5. Bessler M., Mason P.J., Hillmen P., Miyata T., Yamada N., Takeda J., Luzzatto L., Kinoshita T. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 13:1994;110-117.
6. Ware R.E., Rosse W.F., Howard T.A. Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood. 83:1994;2418-2422.
7. Rosse W.F., Ware R.E. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood. 86:1995;3277-3286.
8. Tseng J.E., Hall S.E., Howard T.A., Ware R.E. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria. Am. J. Hematol. 50:1995;244-253.
9. Horikawa K., Nakakuma H., Kawaguchi T., Iwamoto N., Nagakura S., Kagimoto T., Takatsuki K. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood. 90:1997;2716-2722.
10. Brodsky R.A., Vala M.S., Barber J.P., Medof M.E., Jones R.J. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. USA. 94:1997;8756-8760.
11. Ware R.E., Nishimura J., Moody M.A., Smith C., Rosse W.F., Howard T.A. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. Blood. 92:1998;2541-2550.
12. Zimmerman S.A., Malinoski F.J., Ware R.E. Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura. Am. J. Hematol. 57:1998;131-138.
13. Rotoli B., Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Baillieres Clin. Haematol. 2:1989;113-138.
14. Young N.S. The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated. Blood. 79:1992;1385-1392.
15. Nagakura S., Ishihara S., Dunn D.E., Nishimura J., Kawaguchi T., Horikawa K., Hidaka M., Kagimoto T., Eto N., Mitsuya H., Kinoshita T., Young N.S., Nakakuma H. Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro. Blood. 100:2002;1031-1037.
16. Murakami Y., Kosaka H., Maeda Y., Nishimura J., Inoue N., Ohishi K., Okabe M., Takeda J., Kinoshita T. Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood. 100:2002;4116-4122.
17. Chen R., Nagarajan S., Prince G.M., Maheshwari U., Terstappen L.W., Kaplan D.R., Gerson S.L., Albert J.M., Dunn D.E., Lazarus H.M., Medof M.E. Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 106:2000;689-696.
18. Chen G., Kirby M., Zeng W., Young N.S., Maciejewski J.P. Superior growth of glycophosphatidylinositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo. Exp. Hematol. 30:2002;774-782.
19. Ruvolo P.P., Deng X., May W.S. Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia. 15:2001;515-522.
20. Holmgreen S.P., Huang D.C., Adams J.M., Cory S. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members. Cell Death Differ. 6:1999;525-532.
21. Wang C.Y., Guttridge D.C., Mayo M.W., Baldwin A.S. Jr. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19:1999;5923-5929.
22. Hamasaki A., Sendo F., Nakayama K., Ishida N., Negishi I., Nakayama K., Hatakeyama S. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J. Exp. Med. 188:1998;1985-1992.
23. Zhou P., Qian L., Kozopas K.M., Craig R.W. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood. 89:1997;630-643.
24. Myklebust J.H., Josefsen D., Blomhoff H.K., Levy F.O., Naderi S., Reed J.C., Smeland E.B. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J. Cell. Physiol. 180:1999;71-80.
25. Townsend K.J., Zhou P., Qian L., Bieszczad C.K., Lowrey C.H., Yen A., Craig R.W. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J. Biol. Chem. 274:1999;1801-1813.
26. Sugasawa K., Masutani C., Uchida A., Maekawa T., van der Spek P.J., Bootsma D., Hoeijmakers J.H., Hanaoka F. HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro. Mol. Cell. Biol. 16:1996;4852-4861.
27. ′ end cloning artifacts Exp. Eye Res. 59:1994;235-237.
28. Gomez J., Martinez C., Giry M., Garcia A., Rebollo A. Rho prevents apoptosis through Bcl-2 expression: implications for interleukin-2 receptor signal transduction. Eur. J. Immunol. 27:1997;2793-2799.
29. Perona R., Montaner S., Saniger L., Sanchez-Perez I., Bravo R., Lacal J.C. Activation of the nuclear factor-κB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11:1997;463-475.